Objective To explore the personality traits and professional profile of pharmacists, and compare the personality with other majors. Methods This study used 15FQ + personality factor questionnaire for comparing 92 pharmacists,who had been working more than 5 years in pharmacy department of general hospital,with 1064 other different professional staffs,who also had been working more than 5 years. Results The results showed that fA (17.61 ±3.58),fG (16.05 ±5.00),fI (15.82 ±4.26) ,tN (16.74 ±3.78) and fQ3 (18.04 ±3.28)scores of pharmacists were significant higher (P ＜ 0. 05 ), while fC ( 10.61 ± 4.16 ), fE ( 10.84 ± 4.14 ), fL ( 6.33± 4.15 ) and fQ2 ( 8.37 ± 3.94) scores were significant lower (P ＜ 0.05 ). Comparing pharmacists with dentists,fL was significant higher (P＜ 0. 05 ). Comparing with clinical and medical imaging profession, there were significant difference on fA,fI,fL, fM, fQ2 (P ＜ 0.05 ). Comparing with liberal arts and engineering, there were significant difference on fB, fC, fE, fI, fL, fQ1, fQ2 (P ＜ 0. 05 ). Conclusion Comparing with other different professional staffs ,pharmacists have their own personality traits, which are positive, perseverance, sensitive serious, self-discipline and so on. It provides a scientific basis for pharmacists selection and training.

Objective To explore the time course of response inhibition function in juvenile delin-quents with antisocial personality characteristics.Methods The healthy control group ( n=21),juvenile delinquents with antisocial personality characteristics ( CD +AP ) ( n=18) and juvenile delinquents ( CD) ( n=18) were selected in current study by recording the event-related potentials in a Go/Nogo task.N2 and P3 components of event-related potentials were analyzed.Results Behavioral results showed that Nogo cor-rection rate of control group ((93.13±2.71)%) were significantly higher than CD group ((87.51±2.82)%, P<0.01) and CD +AP group((85.63±2.45)%, P<0.01).In CD+AP group,the amplitude of the N2nogo ( (-1.82±1.64)μV) was significantly lower than control group ( (-6.36±2.93)μV, P<0.01) ,and the am-plitude of the P3nogo ((5.52±2.79)μV) was significantly decreased than healthy control ((11.26±4.92)μV, P<0.01).In CD group,the amplitude of P3nogo ((5.20±3.17)μV) was significantly reduced than healthy control ((11.26±4.92)μV, P<0.01).Conclusion N2nogo and N2d are associated with the early phases of response inhibition and reflected response conflict.P3nogo and P3d are associated with the late phases of response inhibition and monitored inhibitory control.These data suggest that CD+AP participants exhibited im-paired response conflict and inhibitory control.This may be associated with persistent antisocial behavior.

OBJECTIVE To synthesize[3H]labelled trantinterol and determine the mass balance in rats and the profile of trantinterol and its metabolites in excreta. METHODS [3H]Trantinterol was synthesised from the intermediate1-(4-amino-3-chloro-5-trifluoromethyl-phenyl)-2-bromo-ethanone through reduction by sodium borotritide and aminolysis by t-butylamine. Following an oral dose of[3H] trantinterol(45.5 MBq·kg-1)to bile duct cannulated(BDC)rats and normal rats. Bile,urine and faeces were collected individually before and after dosing at different times. Liquid scintillation counter(LSC) was used to detect total radioactivity recovery and HPLC/radio-detector for metabolite profiling in urine and bile. RESULTS The majority(73.6%)of the administered radioactivity was recovered in the first 24 h postdose with 48.3%in urine and 25.4%in faeces. It was cumulated to(84.7±6.8)%till 168 h. In BDC rats,29.3%of the dose was recovered in the bile 3 d post-dose. According to the peak area ratio determined by HPLC/radio-detector,only 4.7%and 9.5%of the radioactive dose were excreted as the parent drug in urine and bile,respectively,while the majority of the remaining radioactivity was excreted in the form of various metabolites. CONCLUSION Following oral administration in rats,trantinterol is completely absorbed,extensively metabolized and rapidly excreted mainly in urine as various metabolites.

Moyamoya disease is a chronic progressive cerebrovascular disease. Its disability rate and lethality rate are higher. The direct and indirect revascularization can increase cerebral blood flow and reduce the occurrence of cerebral ischemia and cerebral hemorrhage. This article reviews the pathophysiological basis of its surgical treatment, surgical timing, indications, surgical treatment methods and efficacy.